Protagonist Therapeutics, Inc — Director's Dealing 2017

Aug 31, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Protagonist Therapeutics, Inc (PTGX)
CIK: 0001377121
Period of Report: 2017-08-29

Reporting Person: Shames Richard S. (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-29	Common Stock	M	1512	$4.21	Acquired	3377	Direct
2017-08-29	Common Stock	S	1512	$17.00	Disposed	1865	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-29	Stock Option (right to buy)	$4.21	M	1512	Disposed	2026-04-29	Common Stock (1512)	Direct

Footnotes

F1: Includes 1,865 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2017.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 9, 2017.

F3: The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date.